Evaluation of the molecular effects of metformin and improvement of symptoms in osteoarthritis patients
Phase 2
- Conditions
- Osteoarthritis.Osteoarthritis of knee
- Registration Number
- IRCT20150202020908N2
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Obesity
Inflammatory osteoarthritis
Exclusion Criteria
Autoimmune disease
Age under 18 years old
Cancer
Inflammatory bowel disease
Diabetes mellitus
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method WOMAC questionnaire score. Timepoint: At the beginning of the study (before the intervention) and 16 weeks after starting metformin. Method of measurement: WOMAC questionnaire.
- Secondary Outcome Measures
Name Time Method